Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab.

Furer V, Zisman D, Kaufman I, Arad U, Berman M, Sarbagil-Maman H, Elias M, Hadad A, Paran D, Drori Y, Friedman N, Mandelboim M, Elkayam O.

Vaccine. 2020 Jan 22;38(4):847-851. doi: 10.1016/j.vaccine.2019.10.081. Epub 2019 Nov 22.

PMID:
31767465
2.

Quadrivalent versus trivalent influenza vaccine: clinical outcomes in two influenza seasons, historical cohort study.

Shasha D, Valinsky L, Hershkowitz Sikron F, Glatman-Freedman A, Mandelboim M, Toledano A, Paran Y, Ben-Ami R, Goldman D.

Clin Microbiol Infect. 2020 Jan;26(1):101-106. doi: 10.1016/j.cmi.2019.05.003. Epub 2019 May 17.

PMID:
31108229
3.

Rhinovirus infections in infants suggest that early detection can prevent unnecessary treatment.

Pomeranz G, Pando R, Hindiyeh M, Sherbany H, Meningher T, Sharabi S, Kolet L, Pomeranz A, Mendelson E, Mandelboim M.

J Clin Virol. 2019 Jun;115:11-17. doi: 10.1016/j.jcv.2019.03.012. Epub 2019 Mar 21.

PMID:
30952067
4.

Cell composition analysis of bulk genomics using single-cell data.

Frishberg A, Peshes-Yaloz N, Cohn O, Rosentul D, Steuerman Y, Valadarsky L, Yankovitz G, Mandelboim M, Iraqi FA, Amit I, Mayo L, Bacharach E, Gat-Viks I.

Nat Methods. 2019 Apr;16(4):327-332. doi: 10.1038/s41592-019-0355-5. Epub 2019 Mar 18.

5.

A method to identify respiratory virus infections in clinical samples using next-generation sequencing.

Kustin T, Ling G, Sharabi S, Ram D, Friedman N, Zuckerman N, Bucris ED, Glatman-Freedman A, Stern A, Mandelboim M.

Sci Rep. 2019 Feb 22;9(1):2606. doi: 10.1038/s41598-018-37483-w.

6.

Comparison of the new fully automated extraction platform eMAG to the MagNA PURE 96 and the well-established easyMAG for detection of common human respiratory viruses.

Hindiyeh M, Mor O, Pando R, Mannasse B, Kabat A, Assraf-Zarfati H, Mendelson E, Sofer D, Mandelboim M.

PLoS One. 2019 Feb 19;14(2):e0211079. doi: 10.1371/journal.pone.0211079. eCollection 2019.

7.

Intensive Care Admissions and Associated Severity of Influenza B Versus A During Influenza B Vaccine-mismatched Seasons.

Korem M, Orenbuch-Harroch E, Ben-Chetrit E, Israel S, Cohen MJ, Sviri S, Levin PD, Mandelboim M, Wolf DG.

Clin Infect Dis. 2019 Aug 30;69(6):1049-1052. doi: 10.1093/cid/ciz053.

PMID:
30715225
8.

Publisher Correction: m6A modification controls the innate immune response to infection by targeting type I interferons.

Winkler R, Gillis E, Lasman L, Safra M, Geula S, Soyris C, Nachshon A, Tai-Schmiedel J, Friedman N, Le-Trilling VTK, Trilling M, Mandelboim M, Hanna JH, Schwartz S, Stern-Ginossar N.

Nat Immunol. 2019 Feb;20(2):243. doi: 10.1038/s41590-019-0314-4.

PMID:
30635652
9.

m6A modification controls the innate immune response to infection by targeting type I interferons.

Winkler R, Gillis E, Lasman L, Safra M, Geula S, Soyris C, Nachshon A, Tai-Schmiedel J, Friedman N, Le-Trilling VTK, Trilling M, Mandelboim M, Hanna JH, Schwartz S, Stern-Ginossar N.

Nat Immunol. 2019 Feb;20(2):173-182. doi: 10.1038/s41590-018-0275-z. Epub 2018 Dec 17. Erratum in: Nat Immunol. 2019 Jan 11;:.

PMID:
30559377
10.

A false-positive Trichomonas vaginalis result due to Trichomonas tenax presence in clinical specimens may reveal a possible T. tenax urogenital infection.

Brosh-Nissimov T, Hindiyeh M, Azar R, Smollan G, Belausov N, Mandelboim M, Rahav G, Keller N, Gefen-Halevi S.

Clin Microbiol Infect. 2019 Jan;25(1):123-124. doi: 10.1016/j.cmi.2018.09.011. Epub 2018 Sep 26. No abstract available.

11.

Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1.

Friedman N, Alter H, Hindiyeh M, Mendelson E, Shemer Avni Y, Mandelboim M.

Viruses. 2018 Sep 21;10(10). pii: E515. doi: 10.3390/v10100515.

12.

Characterization of human parainfluenza virus-3 circulating in Israel, 2012-2015.

Jornist I, Muhsen K, Ram D, Lustig Y, Levy V, Orzitser S, Azar R, Weil M, Indenbaum V, Sofer D, Mendelson E, Mandelboim M, Hindiyeh M.

J Clin Virol. 2018 Oct;107:19-24. doi: 10.1016/j.jcv.2018.08.004. Epub 2018 Aug 13.

PMID:
30114677
13.

Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.

Yaron-Yakoby H, Sefty H, Pando R, Dichtiar R, Katz MA, Stein Y, Mandelboim M, Mendelson E, Shohat T, Glatman-Freedman A; The Israeli Influenza Surveillance Network (IISN).

Euro Surveill. 2018 Feb;23(7). doi: 10.2807/1560-7917.ES.2018.23.7.17-00026.

14.

Forty five percent of the Israeli population were infected with the influenza B Victoria virus during the winter season 2015-16.

Sharabi S, Bassal R, Friedman N, Drori Y, Alter H, Glatman-Freedman A, Hindiyeh M, Cohen D, Mendelson E, Shohat T, Mandelboim M.

Oncotarget. 2017 Dec 22;9(5):6623-6629. doi: 10.18632/oncotarget.23601. eCollection 2018 Jan 19.

15.

Exceptional influenza morbidity in summer season of 2017 in Israel may predict the vaccine efficiency in the coming winter.

Pando R, Sharabi S, Mandelboim M.

Vaccine. 2018 Mar 7;36(11):1326-1329. doi: 10.1016/j.vaccine.2018.01.085.

PMID:
29429813
16.

Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis.

Stein Y, Mandelboim M, Sefty H, Pando R, Mendelson E, Shohat T, Glatman-Freedman A; Israeli Influenza Surveillance Network (IISN).

Clin Infect Dis. 2018 Apr 17;66(9):1383-1391. doi: 10.1093/cid/cix1013.

PMID:
29145568
17.

Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression.

Glasner A, Isaacson B, Viukov S, Neuman T, Friedman N, Mandelboim M, Sexl V, Hanna JH, Mandelboim O.

Sci Rep. 2017 Oct 12;7(1):13090. doi: 10.1038/s41598-017-12998-w.

18.

NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.

Bar-On Y, Charpak-Amikam Y, Glasner A, Isaacson B, Duev-Cohen A, Tsukerman P, Varvak A, Mandelboim M, Mandelboim O.

J Virol. 2017 Sep 12;91(19). pii: e01045-17. doi: 10.1128/JVI.01045-17. Print 2017 Oct 1.

19.

Genetic divergence of Influenza A(H3N2) amino acid substitutions mark the beginning of the 2016-2017 winter season in Israel.

Glatman-Freedman A, Drori Y, Beni SA, Friedman N, Pando R, Sefty H, Tal I, McCauley J, Rahav G, Keller N, Shohat T, Mendelson E, Hindiyeh M, Mandelboim M.

J Clin Virol. 2017 Aug;93:71-75. doi: 10.1016/j.jcv.2017.05.020. Epub 2017 Jun 4.

20.

Is the association between hip fractures and seasonality modified by influenza vaccination? An ecological study.

Fraenkel M, Yitshak-Sade M, Beacher L, Carmeli M, Mandelboim M, Siris E, Novack V.

Osteoporos Int. 2017 Sep;28(9):2611-2617. doi: 10.1007/s00198-017-4077-1. Epub 2017 May 23.

PMID:
28536736
21.

A(H1N1)pdm09 influenza infection: vaccine inefficiency.

Friedman N, Drori Y, Pando R, Glatman-Freedman A, Sefty H, Bassal R, Stein Y, Shohat T, Mendelson E, Hindiyeh M, Mandelboim M.

Oncotarget. 2017 May 16;8(20):32856-32863. doi: 10.18632/oncotarget.16459.

22.

Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.

Kovalyuk N, Kaiserman I, Mimouni M, Cohen O, Levartovsky S, Sherbany H, Mandelboim M.

Acta Ophthalmol. 2017 Dec;95(8):e686-e692. doi: 10.1111/aos.13416. Epub 2017 Mar 25.

23.

NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection.

Diab M, Glasner A, Isaacson B, Bar-On Y, Drori Y, Yamin R, Duev-Cohen A, Danziger O, Zamostiano R, Mandelboim M, Jonjic S, Bacharach E, Mandelboim O.

Eur J Immunol. 2017 Apr;47(4):692-703. doi: 10.1002/eji.201646756. Epub 2017 Mar 6.

24.

Influenza A(H1N1)pdm 2009 and influenza B virus co-infection in hospitalized and non-hospitalized patients during the 2015-2016 epidemic season in Israel.

Pando R, Drori Y, Friedman N, Glatman-Freedman A, Sefty H, Shohat T, Mendelson E, Hindiyeh M, Mandelboim M.

J Clin Virol. 2017 Mar;88:12-16. doi: 10.1016/j.jcv.2017.01.002. Epub 2017 Jan 6.

PMID:
28088665
25.

Human enterovirus D68 in clinical and sewage samples in Israel.

Weil M, Mandelboim M, Mendelson E, Manor Y, Shulman L, Ram D, Barkai G, Shemer Y, Wolf D, Kra-Oz Z, Weiss L, Pando R, Hindiyeh M, Sofer D.

J Clin Virol. 2017 Jan;86:52-55. doi: 10.1016/j.jcv.2016.11.013. Epub 2016 Nov 30.

PMID:
27930928
26.

Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality.

Talmi-Frank D, Altboum Z, Solomonov I, Udi Y, Jaitin DA, Klepfish M, David E, Zhuravlev A, Keren-Shaul H, Winter DR, Gat-Viks I, Mandelboim M, Ziv T, Amit I, Sagi I.

Cell Host Microbe. 2016 Oct 12;20(4):458-470. doi: 10.1016/j.chom.2016.09.005.

27.

Suppression of human metapneumovirus (HMPV) infection by the innate sensing gene CEACAM1.

Diab M, Vitenshtein A, Drori Y, Yamin R, Danziger O, Zamostiano R, Mandelboim M, Bacharach E, Mandelboim O.

Oncotarget. 2016 Oct 11;7(41):66468-66479. doi: 10.18632/oncotarget.11979.

28.

Epidemiological and Virological Characterization of Influenza B Virus Infections.

Sharabi S, Drori Y, Micheli M, Friedman N, Orzitzer S, Bassal R, Glatman-Freedman A, Shohat T, Mendelson E, Hindiyeh M, Mandelboim M.

PLoS One. 2016 Aug 17;11(8):e0161195. doi: 10.1371/journal.pone.0161195. eCollection 2016.

29.

A systematic view on influenza induced host shutoff.

Bercovich-Kinori A, Tai J, Gelbart IA, Shitrit A, Ben-Moshe S, Drori Y, Itzkovitz S, Mandelboim M, Stern-Ginossar N.

Elife. 2016 Aug 15;5. pii: e18311. doi: 10.7554/eLife.18311.

30.

Corrigendum to "Outbreak of adenovirus type 55 infection in Israel" [J. Clin. Virol. 78 (2016) 31-35].

Salama M, Amitai Z, Nutman A, Gottesman-Yekutieli T, Sherbany H, Drori Y, Mendelson E, Carmeli Y, Mandelboim M.

J Clin Virol. 2016 Sep;82:183. doi: 10.1016/j.jcv.2016.06.014. Epub 2016 Jul 18. No abstract available.

PMID:
27523612
31.

Human metapneumovirus (hMPV) infection in immunocompromised children.

Scheuerman O, Barkai G, Mandelboim M, Mishali H, Chodick G, Levy I.

J Clin Virol. 2016 Oct;83:12-6. doi: 10.1016/j.jcv.2016.06.006. Epub 2016 Jun 17.

PMID:
27522636
32.

Superiority of West Nile Virus RNA Detection in Whole Blood for Diagnosis of Acute Infection.

Lustig Y, Mannasse B, Koren R, Katz-Likvornik S, Hindiyeh M, Mandelboim M, Dovrat S, Sofer D, Mendelson E.

J Clin Microbiol. 2016 Sep;54(9):2294-7. doi: 10.1128/JCM.01283-16. Epub 2016 Jun 22.

33.

Model-based reconstruction of an epidemic using multiple datasets: understanding influenza A/H1N1 pandemic dynamics in Israel.

Yaari R, Katriel G, Stone L, Mendelson E, Mandelboim M, Huppert A.

J R Soc Interface. 2016 Mar;13(116). pii: 20160099. doi: 10.1098/rsif.2016.0099.

34.

Outbreak of adenovirus type 55 infection in Israel.

Salama M, Amitai Z, Amir N, Gottesman-Yekutieli T, Sherbany H, Drori Y, Mendelson E, Carmeli Y, Mandelboim M.

J Clin Virol. 2016 May;78:31-5. doi: 10.1016/j.jcv.2016.03.002. Epub 2016 Mar 4. Erratum in: J Clin Virol. 2016 Sep;82:183.

PMID:
26971165
35.

The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity.

Duev-Cohen A, Bar-On Y, Glasner A, Berhani O, Ophir Y, Levi-Schaffer F, Mandelboim M, Mandelboim O.

Oncotarget. 2016 Mar 15;7(11):13093-105. doi: 10.18632/oncotarget.7597.

36.

Ineffectiveness of the 2014-2015 H3N2 influenza vaccine.

Mandelboim M, Glatman-Freedman A, Drori Y, Sherbany H, Pando R, Sefty H, Zadka H, Shohat T, Keller N, Mendelson E.

Oncotarget. 2016 Jan 12;7(2):1185-92. doi: 10.18632/oncotarget.6746.

37.

Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome.

Ablin JN, Aloush V, Brill A, Berman M, Barzilai M, Caspi D, Mandelboim M, Levartovsky D, Polachek A, Wolman Y, Paran D, Barkagan M, Elkayam O.

Reumatismo. 2015 Sep 16;67(2):57-61. doi: 10.4081/reumatismo.2015.823.

38.

Back-to-school upper respiratory infection in preschool and primary school-age children in Israel.

Perry Markovich M, Glatman-Freedman A, Bromberg M, Augarten A, Sefty H, Kaufman Z, Sherbany H, Regev L, Chodick G, Mendelson E, Shohat T, Mandelboim M; Israel Pediatric Upper Respiratory Infection Network (IPURIN).

Pediatr Infect Dis J. 2015 May;34(5):476-81. doi: 10.1097/INF.0000000000000627.

PMID:
25879647
39.

Immunogenicity and safety of vaccination against seasonal 2012 influenza virus among patients with psoriatic arthritis and psoriasis.

Polachek A, Korobko U, Mader-Balakirski N, Arad U, Levartovsky D, Kaufman I, Anouk M, Litinsky I, Wigler I, Mendelson E, Paran D, Matz H, Caspi D, Mandelboim M, Elkayam O.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):181-6. Epub 2015 Feb 18.

PMID:
25738420
40.

Return of pandemic H1N1 influenza virus.

Sherbany H, McCauley J, Meningher T, Hindiyeh M, Dichtiar R, Markovich MP, Mendelson E, Mandelboim M.

BMC Infect Dis. 2014 Dec 31;14:710. doi: 10.1186/s12879-014-0710-1.

41.

Children hospitalised with influenza-associated pneumonia during the 2009 pandemic displayed increased disease severity.

Tasher D, Stein M, Solomon C, Shachor-Meyouhas Y, Glikman D, Mandelboim M, Kassis I, Somekh E.

Acta Paediatr. 2015 Mar;104(3):e100-5. doi: 10.1111/apa.12865. Epub 2015 Jan 30.

PMID:
25400278
42.

Significant cross reactive antibodies to influenza virus in adults and children during a period of marked antigenic drift.

Mandelboim M, Bromberg M, Sherbany H, Zucker I, Yaary K, Bassal R, Dichtiar R, Cohen D, Shohat T, Mendelson E, Green MS.

BMC Infect Dis. 2014 Jun 20;14:346. doi: 10.1186/1471-2334-14-346.

43.

Relationships between A(H1N1)pdm09 influenza infection and infections with other respiratory viruses.

Meningher T, Hindiyeh M, Regev L, Sherbany H, Mendelson E, Mandelboim M.

Influenza Other Respir Viruses. 2014 Jul;8(4):422-30. doi: 10.1111/irv.12249. Epub 2014 Apr 4.

44.

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.

Hirsh S, Hindiyeh M, Kolet L, Regev L, Sherbany H, Yaary K, Mendelson E, Mandelboim M.

PLoS One. 2014 Mar 3;9(3):e90515. doi: 10.1371/journal.pone.0090515. eCollection 2014.

45.

Digital cell quantification identifies global immune cell dynamics during influenza infection.

Altboum Z, Steuerman Y, David E, Barnett-Itzhaki Z, Valadarsky L, Keren-Shaul H, Meningher T, Mendelson E, Mandelboim M, Gat-Viks I, Amit I.

Mol Syst Biol. 2014 Feb 28;10:720. doi: 10.1002/msb.134947. Print 2014.

46.

Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors.

Bar-On Y, Seidel E, Tsukerman P, Mandelboim M, Mandelboim O.

J Infect Dis. 2014 Aug 1;210(3):410-8. doi: 10.1093/infdis/jiu094. Epub 2014 Feb 14.

47.

Evaluation of Simplexa Flu A/B & RSV for direct detection of influenza viruses (A and B) and respiratory syncytial virus in patient clinical samples.

Hindiyeh M, Kolet L, Meningher T, Weil M, Mendelson E, Mandelboim M.

J Clin Microbiol. 2013 Jul;51(7):2421-4. doi: 10.1128/JCM.00286-13. Epub 2013 May 8.

48.

Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses.

Bar-On Y, Glasner A, Meningher T, Achdout H, Gur C, Lankry D, Vitenshtein A, Meyers AFA, Mandelboim M, Mandelboim O.

Cell Rep. 2013 Apr 25;3(4):1044-50. doi: 10.1016/j.celrep.2013.03.034. Epub 2013 Apr 18.

49.

Polymerase-chain-reaction-based diagnosis of viral pulmonary infections in immunocompromised children.

Kadmon G, Levy I, Mandelboim M, Nahum E, Stein J, Dovrat S, Schonfeld T.

Acta Paediatr. 2013 Jun;102(6):e263-8. doi: 10.1111/apa.12207. Epub 2013 Mar 28.

PMID:
23421914
50.

The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel.

Weil M, Shohat T, Bromberg M, Bassal R, Dichtiar R, Mandelboim M, Sofer D, Cohen D, Mendelson E.

Influenza Other Respir Viruses. 2013 Sep;7(5):838-46. doi: 10.1111/irv.12071. Epub 2012 Dec 22.

Supplemental Content

Loading ...
Support Center